Generation Bio (NASDAQ:GBIO) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
‘Zombie' biotech buyer Xoma to acquire Generation Bio [Yahoo! Finance]
Generation Bio (NASDAQ:GBIO) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $5.50 price target on the stock, down previously from $7.00.
NodThera Appoints Geoff McDonough, M.D., as Independent Board Member [Yahoo! Finance]
NodThera Appoints Geoff McDonough, M.D., as Independent Board Member